Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06084195

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance

Detailed description

After being informed about the study and potential risks, all patient giving wirtting informed consent. During surgery, tissue and blood samples will be conserved for the study. In this study will be compared images obtained in vivo before surgical management, ex vivo images obtained on excised tissues during surgery, histological data obtained during surgery.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sample and tissue sampleDuring the surgery : * Tissus sample : primary tumor and metastasis * blood sample : 3 EDTA tubes * ex vivo MRI data

Timeline

Start date
2023-12-19
Primary completion
2026-10-01
Completion
2029-10-01
First posted
2023-10-16
Last updated
2025-02-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06084195. Inclusion in this directory is not an endorsement.

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging (NCT06084195) · Clinical Trials Directory